Related Experiment Video
Updated: May 4, 2026

Remote Laboratory Management: Respiratory Virus Diagnostics
Published on: April 6, 2019
International infrastructure to control infectious diseases.
1Health Sciences Division, Rockefeller Foundation, 1133 Avenue of the Americas, 10036, New York, NY, USA.
Significant progress in infectious disease control has increased life expectancy. Further reductions in child mortality require economic improvements, sanitation, education, and targeted immunization programs.
Area of Science:
- Global health
- Infectious disease control
- Child mortality
Background:
- The 20th century saw major advances in controlling infectious diseases, extending life expectancy for a portion of the global population.
- Significant disparities remain in life expectancy and child mortality rates worldwide.
- Addressing child mortality requires comprehensive strategies beyond immediate medical interventions.
Purpose of the Study:
- To review the leading causes of child mortality and their associated socioeconomic factors.
- To evaluate the impact of current interventions and investments on child mortality.
- To identify key areas for future research and programmatic development in infectious disease control.
Main Methods:
- Review of existing literature on infectious disease control and child mortality.
- Analysis of social and economic correlates of child mortality.
- Assessment of the effectiveness and cost-efficiency of current public health programs.
Main Results:
- Infectious disease control has led to substantial gains in life expectancy.
- Economic development, sanitation, education, and nutrition are crucial for reducing child mortality.
- Vertical programs like the Expanded Program on Immunization offer cost-effective, immediate reductions in child mortality.
Conclusions:
- Sustained reductions in child mortality necessitate integrated approaches combining structural changes with targeted health programs.
- Continued investment in development and research is vital for improving infectious disease control efficacy and cost-effectiveness.
- Multinational and bilateral agencies play a key role in supporting these essential changes.
More Related Videos
09:36Safety Precautions and Operating Procedures in an ABSL-4 Laboratory: 4. Medical Imaging Procedures
Published on: October 3, 2016
09:54Safety Precautions and Operating Procedures in an ABSL-4 Laboratory: 1. Biosafety Level 4 Suit Laboratory Suite Entry and Exit Procedures
Published on: October 3, 2016
Related Concept Videos
Infection
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
International Nursing Organizations II
The WHO provides expert team support, including funding, vaccines, testing, and treatment tools at the country level to fight...
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Infectious Diseases and Their Occurrence
International Nursing Organizations I
ICN member organizations work to advance the field of nursing and healthcare via policies, partnerships, lobbying, professional...
Reservoir of Infection